Trial Profile
Pharmacokinetics and tolerability of a drug-device combination of ProANF 31-67 [vessel dilator (VSDL) peptide] and an infusion delivery pump in patients with congestive heart failure
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 31 May 2012
Price :
$35
*
At a glance
- Drugs Atrial natriuretic factor (Primary)
- Indications Heart failure
- Focus Adverse reactions; Pharmacokinetics
- 31 May 2012 New trial record